Search results (22)
« Back to NewsResearch Spotlight: The IRONMUM Trial at SMRU
16 Dec, 2025
IRONMUM is one example of SMRU’s long-standing collaboration with global partners to address critical health challenges in low- and middle-income settings. Through partnerships with institutions such as the University of Oxford and the Mahidol Oxford Tropical Medicine Research Unit (MORU), SMRU conducts research that is firmly grounded in local realities, ensuring that preventive strategies and treatments are effective where they are needed most. Working on the Thailand–Myanmar border since 1986, SMRU combines research, clinical care, and humanitarian action to improve the health of mothers, children, and vulnerable populations affected by infectious diseases and limited access to healthcare.
Analysis of SMRU samples could lead to vaccine for multiple childhood infections
21 Nov, 2025
The first large-scale genomic exploration of H. influenzae, a bacteria that causes 200m infections per year in children worldwide, has revealed extensive antibiotic resistance and uncovered genetic clues that could help in future vaccine development, say researchers from Wellcome Sanger Institute, the Universities of Oxford and Oslo, and MORU’s Shoklo Malaria Research Unit (SMRU) and Cambodia-Oxford Medical Research Unit (COMRU).
Faulty malaria rapid test raises global concerns, say MORU researchers
5 Nov, 2025
A new study published in Malaria Journal warns that a widely used malaria rapid diagnostic test by Abbott Diagnostics may be delivering false-negative results, risking delayed treatment and fuelling malaria transmission. Researchers from SMRU have called for the test’s withdrawal, citing evidence from Southeast Asia.
FD-TACT malaria treatment trial launches patient recruitment in Rwanda
8 Oct, 2025
A Phase 3 pivotal trial, led by MORU and funded by Japan’s Global Health Innovative Technology Fund (GHIT), has begun to evaluate a novel fixed-dose triple artemisinin-based combination treatment (FD-TACT) for uncomplicated Plasmodium falciparum malaria.
Study finds methaemoglobin levels could predict malaria recurrence
26 Nov, 2024
A new study has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.
Dialogue drama on adolescent pregnancy in a marginalised migrant population on the Thailand-Myanmar border
20 Nov, 2024
A participatory-action approach involving community members and adolescents resulted in a dialogue-drama on adolescent pregnancy, contraception, and choice in the event of an unplanned pregnancy. The dialogue-drama augmented discussion of traditionally taboo issues and this ethnographic method is potentially useful for similar global health settings.
Children with acute malnutrition and malaria: the double burden that increases risk of treatment failure
13 Mar, 2024
An analysis of over 11,000 falciparum malaria individual patient data sets has found that acutely malnourished children have a higher risk of reinfections and treatment failures, even when treated with recommended doses of artemisinin-based combination therapies, currently the best malaria treatment available. The malaria parasite clearance was also likely to be longer in these children.
New evidence supports higher dose antimalarial to combat relapsing malaria
26 Sep, 2023
Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in Plasmodium vivax malaria endemic countries.
Identifying factors for maternal and foetal mortality from malaria
31 Aug, 2023
A study coordinated by NDM researchers published in BMC Medicine explores the factors predicting higher mortality in pregnant women with severe malaria and describes how severe falciparum malaria in pregnancy affects foetal health and mortality.
Are we getting tafenoquine dosing right?
6 Dec, 2022
Researchers analysing clinical trial data for the new antimalarial drug tafenoquine find that higher doses are needed to cure reliably vivax malaria infection.
Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy
29 Nov, 2022
A new WWARN meta-analysis, commissioned by the World Health Organization and which informed a change to its treatment guidelines, has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.
Study shows clear link between antibiotic treatment and acquisition of AMR bacteria in children
19 Oct, 2022
A study of the genetic diversity of Streptococcus pneumoniae, the bacterium responsible for hundreds of thousands of infant deaths each year, found that deep sequencing whole pneumococcal populations gave unsurpassed sensitivity for detecting multiple colonisations and was twice as effective at detecting invasive virulent strains of the bacteria as current best methods, say researchers in a study published in Nature Microbiology.
INTERBIO-21st study findings could help predict infants at risk of obesity
30 Aug, 2022
Fetal abdomen growth and the mother’s blood fat metabolites very early in pregnancy influence a child’s weight, body fat, vision and neurodevelopment at 2 years of age
Field evaluation of EasyScan GO: a digital malaria microscopy device
28 Jun, 2022
Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.
Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes
8 Mar, 2022
A new malaria study using a very large analysis of pooled individual patient data (IPD) from more than 70,000 patients of all ages, has been published in BMC Medicine by the WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group
All-nighter: staying up to fight malaria
24 Nov, 2021
Featured in Nature, Victor Chaumeau collects mosquitoes in Myanmar to better understand how to control malaria.
Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
6 Mar, 2020
From The Lancet Correspondence. In the opening to the 2019 World Malaria Report, entitled Leaving no one behind in the march to a malaria free world, the WHO’s Director-General notes that the scourge of malaria continues to strike hardest against pregnant women and children in Africa.
The disease burden on the Thai-Myanmar border
30 Jan, 2020
Debilitating mosquito-borne diseases pose an increasing threat to migrant workers and refugees just across the border in Thailand, where clinics running on dwindling foreign aid struggle to meet needs. SMRU provides quality health care to the marginalized populations living on both sides of the Thai-Myanmar border, achieved through research and humanitarian services.
Longer follow-up needed for malaria treatment in pregnant women
2 Jul, 2019
New research by Makoto Saito and colleagues at SMRU found that a longer follow-up is required to assess antimalarial drug efficacy in pregnant women. This was found across all drugs assessed in low malaria transmission settings. The report’s authors have called for guidelines specifically for pregnant women and further investigation of optimal follow-up periods in high malaria transmission settings.
Getting rid of malaria possible, if we try something new, say experts
25 Apr, 2018
The rapid elimination of potentially untreatable P. falciparum malaria in South-East Asia is possible, according to a ground-breaking new study published today in The Lancet. The study authors say that setting up community-based malaria clinics for early diagnosis, treatment and monitoring, combined with mass antimalarial drug administration (MDA) to everyone living in ‘hotspot’ areas.